| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 7.21e-14 | 5 | 49 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 4.32e-13 | 6 | 49 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 3.09e-10 | 16 | 49 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.90e-07 | 103 | 49 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.37e-06 | 144 | 49 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | D-mannose binding | 3.90e-05 | 27 | 49 | 3 | GO:0005537 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.06e-04 | 310 | 49 | 6 | GO:0030246 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 1.64e-03 | 95 | 49 | 3 | GO:0048029 | |
| GeneOntologyBiologicalProcess | oligosaccharide metabolic process | 1.94e-05 | 70 | 47 | 4 | GO:0009311 | |
| Domain | Aamy_C | 3.52e-11 | 4 | 47 | 4 | SM00632 | |
| Domain | Alpha_amylase | 3.52e-11 | 4 | 47 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 1.76e-10 | 5 | 47 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 1.76e-10 | 5 | 47 | 4 | IPR006048 | |
| Domain | Aamy | 1.22e-09 | 7 | 47 | 4 | SM00642 | |
| Domain | Alpha-amylase | 1.22e-09 | 7 | 47 | 4 | PF00128 | |
| Domain | Glyco_hydro_13_cat_dom | 1.22e-09 | 7 | 47 | 4 | IPR006047 | |
| Domain | A-amylase_C | 1.49e-08 | 3 | 47 | 3 | IPR031319 | |
| Domain | Glyco_hydro_catalytic_dom | 3.82e-08 | 38 | 47 | 5 | IPR013781 | |
| Domain | Glyco_hydro_b | 4.71e-08 | 15 | 47 | 4 | IPR013780 | |
| Domain | Glycoside_hydrolase_SF | 2.13e-07 | 53 | 47 | 5 | IPR017853 | |
| Domain | Glyco_hydro_13 | 2.97e-07 | 6 | 47 | 3 | IPR015902 | |
| Domain | - | 1.74e-06 | 35 | 47 | 4 | 3.20.20.80 | |
| Domain | - | 5.33e-06 | 14 | 47 | 3 | 2.60.40.1180 | |
| Domain | C-type_lectin_CS | 1.72e-04 | 43 | 47 | 3 | IPR018378 | |
| Domain | Carboxylesterase_B_CS | 4.75e-04 | 13 | 47 | 2 | IPR019819 | |
| Domain | COesterase | 5.53e-04 | 14 | 47 | 2 | PF00135 | |
| Domain | CARBOXYLESTERASE_B_2 | 5.53e-04 | 14 | 47 | 2 | PS00941 | |
| Domain | CarbesteraseB | 5.53e-04 | 14 | 47 | 2 | IPR002018 | |
| Domain | C_TYPE_LECTIN_1 | 1.07e-03 | 80 | 47 | 3 | PS00615 | |
| Domain | FN3 | 1.19e-03 | 185 | 47 | 4 | SM00060 | |
| Domain | Lectin_C | 1.23e-03 | 84 | 47 | 3 | PF00059 | |
| Domain | CLECT | 1.23e-03 | 84 | 47 | 3 | SM00034 | |
| Domain | - | 1.26e-03 | 663 | 47 | 7 | 2.60.40.10 | |
| Domain | C_TYPE_LECTIN_2 | 1.28e-03 | 85 | 47 | 3 | PS50041 | |
| Domain | C-type_lectin-like | 1.32e-03 | 86 | 47 | 3 | IPR001304 | |
| Domain | FN3 | 1.56e-03 | 199 | 47 | 4 | PS50853 | |
| Domain | Ricin_B_lectin | 1.79e-03 | 25 | 47 | 2 | PF00652 | |
| Domain | Ig-like_fold | 1.80e-03 | 706 | 47 | 7 | IPR013783 | |
| Domain | FN3_dom | 1.87e-03 | 209 | 47 | 4 | IPR003961 | |
| Domain | - | 1.87e-03 | 97 | 47 | 3 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 1.98e-03 | 99 | 47 | 3 | IPR016186 | |
| Domain | RICIN | 2.25e-03 | 28 | 47 | 2 | SM00458 | |
| Domain | RICIN_B_LECTIN | 2.25e-03 | 28 | 47 | 2 | PS50231 | |
| Domain | FBG | 2.41e-03 | 29 | 47 | 2 | SM00186 | |
| Domain | CTDL_fold | 2.47e-03 | 107 | 47 | 3 | IPR016187 | |
| Domain | - | 2.58e-03 | 30 | 47 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 2.58e-03 | 30 | 47 | 2 | IPR014716 | |
| Domain | Ricin_B_lectin | 2.58e-03 | 30 | 47 | 2 | IPR000772 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.93e-03 | 32 | 47 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.93e-03 | 32 | 47 | 2 | PS51406 | |
| Domain | FIBRINOGEN_C_1 | 2.93e-03 | 32 | 47 | 2 | PS00514 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 2.29e-11 | 9 | 42 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 8.37e-11 | 11 | 42 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 5.94e-09 | 23 | 42 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.71e-08 | 28 | 42 | 5 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.30e-07 | 52 | 42 | 5 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.36e-06 | 8 | 42 | 3 | MM14717 | |
| Pathway | REACTOME_DIGESTION | 3.15e-05 | 21 | 42 | 3 | MM15526 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 5.40e-05 | 25 | 42 | 3 | MM15557 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | 8.88e-04 | 15 | 42 | 2 | MM14875 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | 1.01e-03 | 16 | 42 | 2 | M627 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 2.70e-14 | 6 | 49 | 5 | 6608795 | |
| Pubmed | 2.70e-14 | 6 | 49 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 2.70e-14 | 6 | 49 | 5 | 2788608 | |
| Pubmed | 2.70e-14 | 6 | 49 | 5 | 2081604 | ||
| Pubmed | 2.70e-14 | 6 | 49 | 5 | 15286789 | ||
| Pubmed | 2.51e-13 | 8 | 49 | 5 | 12414807 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 3.48e-12 | 4 | 49 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 3.48e-12 | 4 | 49 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 3.48e-12 | 4 | 49 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 3.48e-12 | 4 | 49 | 4 | 26098870 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 6160849 | ||
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 3.48e-12 | 4 | 49 | 4 | 4745489 | |
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 3.48e-12 | 4 | 49 | 4 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 3.48e-12 | 4 | 49 | 4 | 94264 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 3872721 | ||
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 3.48e-12 | 4 | 49 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 3.48e-12 | 4 | 49 | 4 | 6207174 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 2410924 | ||
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 3.48e-12 | 4 | 49 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 3.48e-12 | 4 | 49 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 3.48e-12 | 4 | 49 | 4 | 2987507 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 6091898 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 3.48e-12 | 4 | 49 | 4 | 2332419 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 3.48e-12 | 4 | 49 | 4 | 6162108 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 16152770 | ||
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 2423416 | ||
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 3.48e-12 | 4 | 49 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 3.48e-12 | 4 | 49 | 4 | 2989529 | |
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.74e-11 | 5 | 49 | 4 | 34276419 | |
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 6176569 | ||
| Pubmed | 1.74e-11 | 5 | 49 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.74e-11 | 5 | 49 | 4 | 8661735 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 5.20e-11 | 6 | 49 | 4 | 7859283 | |
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 2002257 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 2450406 | ||
| Pubmed | 5.20e-11 | 6 | 49 | 4 | 7946325 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 5.20e-11 | 6 | 49 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 5.20e-11 | 6 | 49 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 5.20e-11 | 6 | 49 | 4 | 9250879 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 5.20e-11 | 6 | 49 | 4 | 1021597 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 1.21e-10 | 7 | 49 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 1.21e-10 | 7 | 49 | 4 | 2451911 | |
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 7949740 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 6160178 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 8604219 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 8666240 | ||
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 2040456 | ||
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 3038891 | ||
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 2.42e-10 | 8 | 49 | 4 | 6200103 | |
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 2.42e-10 | 8 | 49 | 4 | 7523515 | |
| Pubmed | 4.36e-10 | 9 | 49 | 4 | 93520 | ||
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 9121556 | ||
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 12101187 | ||
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 2897103 | ||
| Pubmed | 1.14e-09 | 11 | 49 | 4 | 23449223 | ||
| Pubmed | 1.14e-09 | 11 | 49 | 4 | 2565740 | ||
| Pubmed | 1.14e-09 | 11 | 49 | 4 | 7608209 | ||
| Pubmed | 1.14e-09 | 11 | 49 | 4 | 1617215 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.14e-09 | 11 | 49 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 1.14e-09 | 11 | 49 | 4 | 8589528 | |
| Pubmed | 1.14e-09 | 11 | 49 | 4 | 2903254 | ||
| Pubmed | 1.71e-09 | 12 | 49 | 4 | 8144363 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 2.46e-09 | 13 | 49 | 4 | 7829080 | |
| Pubmed | 2.46e-09 | 13 | 49 | 4 | 489953 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 2.63e-09 | 3 | 49 | 3 | 2413838 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 6098446 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 2.63e-09 | 3 | 49 | 3 | 21827821 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 30982860 | ||
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 2.63e-09 | 3 | 49 | 3 | 6360562 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 2.63e-09 | 3 | 49 | 3 | 2436036 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 1699843 | ||
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 2.63e-09 | 3 | 49 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 2.63e-09 | 3 | 49 | 3 | 17223109 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 15299664 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 12527308 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 2414282 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 8413315 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 28659346 | ||
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 2.63e-09 | 3 | 49 | 3 | 7678001 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 25588701 | ||
| Pubmed | 3.44e-09 | 14 | 49 | 4 | 7894156 | ||
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 3.44e-09 | 14 | 49 | 4 | 8001974 | |
| Pubmed | 3.44e-09 | 14 | 49 | 4 | 2902233 | ||
| Pubmed | 6.25e-09 | 16 | 49 | 4 | 2571572 | ||
| Pubmed | 6.25e-09 | 16 | 49 | 4 | 10842072 | ||
| Pubmed | 8.16e-09 | 17 | 49 | 4 | 25410786 | ||
| Pubmed | 1.05e-08 | 18 | 49 | 4 | 34446743 | ||
| Pubmed | 1.05e-08 | 18 | 49 | 4 | 2338144 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 20939500 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 1.05e-08 | 4 | 49 | 3 | 8543783 | |
| Interaction | AMY2B interactions | 1.50e-06 | 10 | 48 | 3 | int:AMY2B | |
| Interaction | GPR137C interactions | 5.55e-06 | 2 | 48 | 2 | int:GPR137C | |
| Interaction | AMY2A interactions | 1.64e-05 | 21 | 48 | 3 | int:AMY2A | |
| Cytoband | 1p21 | 4.70e-11 | 24 | 49 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 1.10e-07 | 107 | 49 | 5 | chr1p21 | |
| Cytoband | 16q23.1 | 5.42e-04 | 32 | 49 | 2 | 16q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q23 | 1.84e-03 | 226 | 49 | 3 | chr1q23 | |
| Cytoband | 17q25.3 | 5.27e-03 | 101 | 49 | 2 | 17q25.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q12 | 5.47e-03 | 103 | 49 | 2 | chr16q12 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.28e-06 | 394 | 29 | 7 | 471 | |
| GeneFamily | C-type lectin domain family | 5.74e-05 | 47 | 29 | 3 | 494 | |
| GeneFamily | Fibronectin type III domain containing | 2.10e-03 | 160 | 29 | 3 | 555 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP | 8.88e-08 | 200 | 49 | 7 | M8954 | |
| Coexpression | BERGER_MBD2_TARGETS | 1.00e-06 | 11 | 49 | 3 | MM905 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 1.04e-06 | 41 | 49 | 4 | MM698 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 4.87e-06 | 60 | 49 | 4 | MM654 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 1.49e-05 | 432 | 49 | 7 | M41149 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 1.74e-05 | 27 | 49 | 3 | MM643 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 6.62e-05 | 116 | 49 | 4 | MM1240 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 1.09e-04 | 132 | 49 | 4 | MM470 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_UP | 1.42e-04 | 54 | 49 | 3 | MM889 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.49e-04 | 143 | 49 | 4 | MM1056 | |
| Coexpression | BORLAK_LIVER_CANCER_EGF_UP | 1.67e-04 | 57 | 49 | 3 | MM527 | |
| Coexpression | GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP | 1.83e-04 | 151 | 49 | 4 | M6498 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 1.88e-04 | 152 | 49 | 4 | M2938 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN | 2.02e-04 | 289 | 49 | 5 | MM1238 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.18e-04 | 158 | 49 | 4 | MM17063 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN | 2.40e-04 | 162 | 49 | 4 | M7002 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_D_DN | 2.47e-04 | 302 | 49 | 5 | MM1046 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP | 2.63e-04 | 166 | 49 | 4 | MM563 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 2.63e-04 | 166 | 49 | 4 | M7009 | |
| Coexpression | NABA_ECM_AFFILIATED | 2.88e-04 | 170 | 49 | 4 | M5880 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-06 | 179 | 49 | 5 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 1.69e-06 | 182 | 49 | 5 | bb1f815718397de96682697fcbd6014a992a28f7 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 196 | 49 | 5 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 196 | 49 | 5 | 54c30023d04e7265373647f56fc93885804938b0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 161 | 49 | 4 | fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 161 | 49 | 4 | c53c461fc721a7960cef86662f49e2a495520701 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.95e-05 | 161 | 49 | 4 | 1011094c54381d52566e24c92f89f2efc2aa3eea | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 162 | 49 | 4 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 164 | 49 | 4 | a784f47f67a5eda84d58ad7d9400e3978edbb487 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 164 | 49 | 4 | 1a1795969673232191425dde84ab24ee6a98143f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 164 | 49 | 4 | 8f074940afdbda88a4b697a7ddc687e09a4b818b | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.25e-05 | 165 | 49 | 4 | 8d3d5860a4785c4908160ae5fcb421ee80bd78ce | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.25e-05 | 165 | 49 | 4 | 17ee6f269ed8d378465cf00ca59d48d8b106808e | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-05 | 166 | 49 | 4 | 7be2b5c62e2be3437ea50b9a473cf9fc7f05e0b1 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-interstitial_macrophage|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-05 | 166 | 49 | 4 | 8418b191e7f16cb39301df3ddbfb1bab6c0632d6 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 167 | 49 | 4 | 4520ee71e2b119c1dfa0e342fe57eda5f3598650 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.49e-05 | 168 | 49 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-05 | 170 | 49 | 4 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-05 | 170 | 49 | 4 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-05 | 170 | 49 | 4 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-05 | 172 | 49 | 4 | c96bd3407911df3e3e6d7a3dba786b11814b9598 | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-CD163+_Macrophage|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.82e-05 | 172 | 49 | 4 | 9a659442dc41bd2a4361a7e38a7ee37a39781667 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-05 | 173 | 49 | 4 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-05 | 173 | 49 | 4 | 3d7c281a1a9f183a5a861d1a9c7b50d216535893 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-05 | 173 | 49 | 4 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-05 | 173 | 49 | 4 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.91e-05 | 173 | 49 | 4 | 3aa90578371039f81b7c6fa873ec70f8f2bc7dfa | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.00e-05 | 174 | 49 | 4 | 0a8fa44604be19fbac722ebc6d1cd72b71be7022 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-05 | 174 | 49 | 4 | 33e5903adb746f693433bdca11a75c508bbf50c0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-interstitial_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-05 | 174 | 49 | 4 | ca0c2f42544092848541863c4a47b334e6828b8a | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-05 | 175 | 49 | 4 | d983e80eeb11f341c564ea684e2b0b585a90ae58 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 4.46e-05 | 179 | 49 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.46e-05 | 179 | 49 | 4 | fae869fb0a91428481bf8a9c111dcc639e2b4278 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-05 | 180 | 49 | 4 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 181 | 49 | 4 | c7ad10a696d94b9ee91cd7e62761d356d5106eda | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 181 | 49 | 4 | eaa3a2c268cce527004ae656d35e037b984fb4c7 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.86e-05 | 183 | 49 | 4 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 4.86e-05 | 183 | 49 | 4 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-05 | 184 | 49 | 4 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-05 | 184 | 49 | 4 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 5.07e-05 | 185 | 49 | 4 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.07e-05 | 185 | 49 | 4 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.18e-05 | 186 | 49 | 4 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 186 | 49 | 4 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 186 | 49 | 4 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.18e-05 | 186 | 49 | 4 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 187 | 49 | 4 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 49 | 4 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.40e-05 | 188 | 49 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 188 | 49 | 4 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 188 | 49 | 4 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.40e-05 | 188 | 49 | 4 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | facs-BAT-Fat-24m-Epithelial-epithelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 189 | 49 | 4 | faa269cba4c361a41ffa5b5f5632cb43df90195e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-05 | 189 | 49 | 4 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | facs-BAT-Fat-24m-Epithelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 189 | 49 | 4 | 07b164eeb4cd967b056092d5dfce08dd498cdfd1 | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial-Lymphatic_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.63e-05 | 190 | 49 | 4 | 279c5f68b993dc7adbf9aa69fffb1321cdebc48a | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.63e-05 | 190 | 49 | 4 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 5.63e-05 | 190 | 49 | 4 | d82ab67735c1f365d4b0e02b5fa91c64cdc234da | |
| ToppCell | wk_08-11-Endothelial-Lymph_endothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.63e-05 | 190 | 49 | 4 | d7f1dc032d161529559e01832d1a3112c6f6cc1a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.74e-05 | 191 | 49 | 4 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.74e-05 | 191 | 49 | 4 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.74e-05 | 191 | 49 | 4 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 5.86e-05 | 192 | 49 | 4 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 5.86e-05 | 192 | 49 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-05 | 192 | 49 | 4 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-05 | 192 | 49 | 4 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.86e-05 | 192 | 49 | 4 | d43caf42ec744e895137f31ef65a990e250669d2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.98e-05 | 193 | 49 | 4 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.98e-05 | 193 | 49 | 4 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.98e-05 | 193 | 49 | 4 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.98e-05 | 193 | 49 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-05 | 194 | 49 | 4 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | facs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 194 | 49 | 4 | 3701ca87c6dc9ccd7b4146e56371546174d26c36 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 194 | 49 | 4 | 65f9bf126be26114c2c3f4c46d48318986212a92 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-05 | 194 | 49 | 4 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.10e-05 | 194 | 49 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.22e-05 | 195 | 49 | 4 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 195 | 49 | 4 | 98dd3b7d5ef587825dac052dea4d4ff883f6d4d6 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.22e-05 | 195 | 49 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.22e-05 | 195 | 49 | 4 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 6.22e-05 | 195 | 49 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-05 | 196 | 49 | 4 | eb8c9a4a5eb21d43ff7b25deae5896c236f669b9 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 196 | 49 | 4 | ee89f6884aea11aefeaabe043db7f80145dcdf7f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.35e-05 | 196 | 49 | 4 | e75c36cb042342d69a593fb1ce62fab033889871 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.47e-05 | 197 | 49 | 4 | c747d05bb032abf8dad46ff6f4d1951bbe64b3b4 | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.60e-05 | 198 | 49 | 4 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.73e-05 | 199 | 49 | 4 | 7ebd89dff457f57a549eecee288c7a4b515b4018 | |
| ToppCell | normal_Pleural_Fluid-Epithelial_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.73e-05 | 199 | 49 | 4 | 564ba7acd03be2d6e4d0850cb2c7237a788dc275 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.73e-05 | 199 | 49 | 4 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.73e-05 | 199 | 49 | 4 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | 76e90231aa94afc12e618da8ae314c51644acab4 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.86e-05 | 200 | 49 | 4 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.86e-05 | 200 | 49 | 4 | 26f07d271e984f375145e4c10528fba44a5811e1 | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.86e-05 | 200 | 49 | 4 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-BAGE2-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.86e-05 | 200 | 49 | 4 | c3637827ceba16b0d7956c280dd2ddbc8b1ba55e | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.86e-05 | 200 | 49 | 4 | e3e80cb16e0d2e24efc16b62316a6da91bf81ea5 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.86e-05 | 200 | 49 | 4 | 0afd93c4fdcc118bcfa77f3b59f6ff7d9293a7a4 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.86e-05 | 200 | 49 | 4 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 2.24e-13 | 6 | 49 | 5 | CID003083414 | |
| Drug | R 623 | 2.24e-13 | 6 | 49 | 5 | CID003027594 | |
| Drug | dimethylaminomethylferrocene | 2.24e-13 | 6 | 49 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 2.24e-13 | 6 | 49 | 5 | CID000127364 | |
| Drug | CNP-G3 | 2.24e-13 | 6 | 49 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 7.83e-13 | 7 | 49 | 5 | CID000174858 | |
| Drug | BG5P | 7.83e-13 | 7 | 49 | 5 | CID003082752 | |
| Drug | desethylaprophen | 2.09e-12 | 8 | 49 | 5 | CID000163919 | |
| Drug | azintamide | 2.09e-12 | 8 | 49 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 4.68e-12 | 9 | 49 | 5 | CID000194237 | |
| Drug | trestatin A | 4.68e-12 | 9 | 49 | 5 | CID003054994 | |
| Drug | AC1LAC07 | 9.35e-12 | 10 | 49 | 5 | CID000485275 | |
| Drug | Glc)4 | 9.35e-12 | 10 | 49 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 9.35e-12 | 10 | 49 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 9.35e-12 | 10 | 49 | 5 | CID000118008 | |
| Drug | validamycin D | 1.71e-11 | 11 | 49 | 5 | CID000166726 | |
| Drug | FG5P | 1.71e-11 | 11 | 49 | 5 | CID000127486 | |
| Drug | CNP-G5 | 1.71e-11 | 11 | 49 | 5 | CID000127309 | |
| Drug | HgI2 | 1.71e-11 | 11 | 49 | 5 | CID000024485 | |
| Drug | 2C KM | 1.71e-11 | 11 | 49 | 5 | CID009549196 | |
| Drug | 2-nitropropyl acetate | 1.89e-11 | 4 | 49 | 4 | CID013573844 | |
| Drug | N-PMT | 1.89e-11 | 4 | 49 | 4 | CID000194224 | |
| Drug | Dembrexine | 1.89e-11 | 4 | 49 | 4 | CID000072009 | |
| Drug | g lw | 1.89e-11 | 4 | 49 | 4 | CID000444139 | |
| Drug | AC1MQT4V | 1.89e-11 | 4 | 49 | 4 | CID003482066 | |
| Drug | beta-santalene | 1.89e-11 | 4 | 49 | 4 | CID000010534 | |
| Drug | SAIB-SG | 1.89e-11 | 4 | 49 | 4 | CID002735139 | |
| Drug | azaprophen | 2.93e-11 | 12 | 49 | 5 | CID000129486 | |
| Drug | methyl 1'-epiacarviosin | 4.75e-11 | 13 | 49 | 5 | CID000197426 | |
| Drug | isoacarbose | 4.75e-11 | 13 | 49 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 7.38e-11 | 14 | 49 | 5 | CID000024238 | |
| Drug | terephthaloyl chloride | 7.38e-11 | 14 | 49 | 5 | CID000007488 | |
| Drug | 2-chloro-4-nitrophenol | 7.38e-11 | 14 | 49 | 5 | CID000012074 | |
| Drug | actinidine | 9.45e-11 | 5 | 49 | 4 | CID000068231 | |
| Drug | Deposiston | 9.45e-11 | 5 | 49 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 9.45e-11 | 5 | 49 | 4 | CID010358258 | |
| Drug | 2TAA | 9.45e-11 | 5 | 49 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 9.45e-11 | 5 | 49 | 4 | CID006449879 | |
| Drug | silver perchlorate | 9.45e-11 | 5 | 49 | 4 | CID000024562 | |
| Drug | lunularic acid | 9.45e-11 | 5 | 49 | 4 | CID000161413 | |
| Drug | himachalene | 9.45e-11 | 5 | 49 | 4 | CID000015095 | |
| Drug | AC1L4DZ4 | 9.45e-11 | 5 | 49 | 4 | CID000155287 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.11e-10 | 15 | 49 | 5 | CID000173254 | |
| Drug | gamma-cyclodextrin | 1.61e-10 | 16 | 49 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 1.61e-10 | 16 | 49 | 5 | CID003085308 | |
| Drug | 2-amino-6-picoline | 2.83e-10 | 6 | 49 | 4 | CID000015765 | |
| Drug | phenol blue | 2.83e-10 | 6 | 49 | 4 | CID000075078 | |
| Drug | Gu-4 | 2.83e-10 | 6 | 49 | 4 | CID000448679 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 2.83e-10 | 6 | 49 | 4 | CID009577343 | |
| Drug | Borane dimethylamine complex | 2.83e-10 | 6 | 49 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 2.83e-10 | 6 | 49 | 4 | CID000092801 | |
| Drug | AC1OAGH8 | 2.83e-10 | 6 | 49 | 4 | CID006857368 | |
| Drug | vermella | 2.83e-10 | 6 | 49 | 4 | CID000203726 | |
| Drug | hymenin | 2.83e-10 | 6 | 49 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 2.83e-10 | 6 | 49 | 4 | CID000011615 | |
| Drug | trimitan | 3.14e-10 | 18 | 49 | 5 | CID000005561 | |
| Drug | aprophen | 3.14e-10 | 18 | 49 | 5 | CID000071128 | |
| Drug | 3KBG5CNP | 6.59e-10 | 7 | 49 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 6.59e-10 | 7 | 49 | 4 | CID000071762 | |
| Drug | Paramax | 6.59e-10 | 7 | 49 | 4 | CID000156411 | |
| Drug | methyl blue | 6.59e-10 | 7 | 49 | 4 | CID011969534 | |
| Drug | amino-methyl | 6.59e-10 | 7 | 49 | 4 | CID000142005 | |
| Drug | AC1L3XPY | 7.42e-10 | 21 | 49 | 5 | CID000124005 | |
| Drug | maltosaccharide | 9.59e-10 | 22 | 49 | 5 | CID005461034 | |
| Drug | boric acid gel | 1.32e-09 | 8 | 49 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 1.32e-09 | 8 | 49 | 4 | CID005317411 | |
| Drug | theodrenaline | 1.32e-09 | 8 | 49 | 4 | CID000071857 | |
| Drug | N-vinylcaprolactam | 1.32e-09 | 8 | 49 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 1.32e-09 | 8 | 49 | 4 | CID000146692 | |
| Drug | acrinor | 1.32e-09 | 8 | 49 | 4 | CID005489637 | |
| Drug | rhodanile blue | 1.32e-09 | 8 | 49 | 4 | CID000073372 | |
| Drug | NSC300622 | 1.32e-09 | 8 | 49 | 4 | CID000028426 | |
| Drug | Panose B | 1.54e-09 | 24 | 49 | 5 | CID000439297 | |
| Drug | CID439354 | 1.92e-09 | 25 | 49 | 5 | CID000439354 | |
| Drug | Atonik | 2.37e-09 | 9 | 49 | 4 | CID000069471 | |
| Drug | GSAD | 2.37e-09 | 9 | 49 | 4 | CID009909127 | |
| Drug | GU-3 | 2.37e-09 | 9 | 49 | 4 | CID000448687 | |
| Drug | zingiberene | 2.37e-09 | 9 | 49 | 4 | CID000092776 | |
| Drug | H 187 | 2.37e-09 | 9 | 49 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 2.37e-09 | 9 | 49 | 4 | CID000024864 | |
| Drug | I ZE | 3.94e-09 | 10 | 49 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 3.94e-09 | 10 | 49 | 4 | CID000012135 | |
| Drug | CG-120 | 3.94e-09 | 10 | 49 | 4 | CID000171403 | |
| Drug | naphthalene-1,3,6,8-tetrol | 3.94e-09 | 10 | 49 | 4 | CID000440202 | |
| Drug | eicosa-11,14-dienoic acid | 3.94e-09 | 10 | 49 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 3.94e-09 | 10 | 49 | 4 | CID000126789 | |
| Drug | mannan | 4.48e-09 | 63 | 49 | 6 | CID000000870 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 5.12e-09 | 30 | 49 | 5 | CID005373003 | |
| Drug | AMO-1618 | 6.18e-09 | 11 | 49 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 6.18e-09 | 11 | 49 | 4 | CID000430710 | |
| Drug | Tempamine | 6.18e-09 | 11 | 49 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 6.18e-09 | 11 | 49 | 4 | CID000164608 | |
| Drug | Folin Marenzi reagent | 7.21e-09 | 32 | 49 | 5 | CID000452313 | |
| Drug | R625 | 8.49e-09 | 33 | 49 | 5 | CID000072375 | |
| Drug | chitosan | 9.25e-09 | 12 | 49 | 4 | CID000071853 | |
| Drug | Avenin | 9.25e-09 | 12 | 49 | 4 | CID000095924 | |
| Drug | AC1L4W0B | 9.25e-09 | 12 | 49 | 4 | CID000193311 | |
| Drug | 3-hydr-oxy-2-naphthohydrazide | 9.25e-09 | 12 | 49 | 4 | CID000072699 | |
| Drug | H2folate | 9.25e-09 | 12 | 49 | 4 | CID000168809 | |
| Drug | chloroisocyanuric acid | 9.25e-09 | 12 | 49 | 4 | CID000017921 | |
| Disease | alpha-amylase 1 measurement | 7.08e-10 | 9 | 47 | 4 | EFO_0801371 | |
| Disease | dental caries, dentures | 4.80e-06 | 70 | 47 | 4 | EFO_0003819, EFO_0010078 | |
| Disease | dentures | 4.80e-06 | 70 | 47 | 4 | EFO_0010078 | |
| Disease | Headache, glucose measurement | 8.88e-05 | 9 | 47 | 2 | EFO_0004468, HP_0002315 | |
| Disease | t-tau measurement | 1.07e-03 | 126 | 47 | 3 | EFO_0004760 | |
| Disease | interleukin-8 measurement | 1.12e-03 | 31 | 47 | 2 | EFO_0004811 | |
| Disease | fasting blood glucose measurement | 1.13e-03 | 287 | 47 | 4 | EFO_0004465 | |
| Disease | stroke | 1.58e-03 | 144 | 47 | 3 | EFO_0000712 | |
| Disease | Parkinson disease, disease progression measurement | 1.77e-03 | 39 | 47 | 2 | EFO_0008336, MONDO_0005180 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.84e-03 | 152 | 47 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | autistic disorder (is_implicated_in) | 2.05e-03 | 42 | 47 | 2 | DOID:12849 (is_implicated_in) | |
| Disease | non-alcoholic fatty liver disease | 3.07e-03 | 182 | 47 | 3 | EFO_0003095 | |
| Disease | neutrophil-to-lymphocyte ratio | 3.21e-03 | 185 | 47 | 3 | EFO_0008447 | |
| Disease | sarcoidosis | 4.70e-03 | 64 | 47 | 2 | MONDO_0019338 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WEEQAYSNCSGPGFS | 121 | P28330 | |
| VYNPSEGSTWNPFDD | 686 | Q2M2I8 | |
| PSDNGQYWCHFQDGN | 116 | Q9UIR0 | |
| QDSPDGQYENSEGGW | 646 | P56945 | |
| VDGQPFTNWYDNGSN | 416 | P0DTE7 | |
| VDGQPFTNWYDNGSN | 416 | P0DTE8 | |
| NETQTYWGGSSPDLQ | 706 | Q9C0A0 | |
| WNSSYGVNDSFPDGD | 26 | Q16570 | |
| GQPSWADQEYRGSFT | 96 | Q9HC96 | |
| VDGQPFTNWYDNGSN | 416 | P0DUB6 | |
| VDGQPFTNWYDNGSN | 416 | P19961 | |
| WDSQQDGSGYESDGA | 576 | Q9C0H5 | |
| VDGQPFTNWYDNGSN | 416 | P04746 | |
| FSASGWQPGTEYDNV | 391 | O60496 | |
| PEGDGNWANYNTFGS | 111 | Q8WWA0 | |
| YAFWQSSEDAGTGDP | 481 | O43525 | |
| SQDTLESPFNYGWDN | 271 | Q8N3F9 | |
| SGNGSWTDPVFFYVQ | 911 | P08069 | |
| SWGSDAEQSTSGQPY | 311 | Q96JN0 | |
| YWATFARTGNPNGND | 491 | Q6NT32 | |
| SNIVPQDFDNNSGYW | 161 | Q9Y2C4 | |
| LDDHDYGSWGNYNNP | 291 | Q6UWI2 | |
| PAYSNENAQGSWNGD | 676 | Q9NZ94 | |
| VTGYEGPAQQNFEWF | 51 | Q969P0 | |
| QGWNRSYPFNNGDLT | 4046 | Q9UFH2 | |
| DWNTFEYLGNSGEPQ | 261 | Q8IXK2 | |
| EAWVSQNPNSNYFGD | 516 | O00462 | |
| DTWDYTNPNLSGQGD | 281 | P14866 | |
| FWPTAQNSGGSAYSE | 351 | Q9HBE5 | |
| GSGDPSSFWNQYAAA | 1226 | Q9NSC2 | |
| GPQWYQESQESESEG | 26 | Q3KNS1 | |
| YESIDPGQQFTWENS | 1356 | P10586 | |
| SQDSWEQNYSPGEGF | 1236 | Q8TEW0 | |
| DYVSWATGEPNFANE | 881 | P22897 | |
| YSEDNSEQWGSFPIS | 1416 | O60469 | |
| VNNYTNSFGGEWSAP | 451 | Q14134 | |
| DGTSAWGDPSNYNNK | 726 | Q9HCJ0 | |
| ALSSWGQQPSSGYQE | 1556 | Q8WUY3 | |
| DSDGVNYPWYGNTTE | 126 | Q5JUQ0 | |
| SSGDGNSFYTQWGNQ | 336 | O00444 | |
| QSSTSDEEPGAYWNG | 116 | Q9P2M7 | |
| NAWTFFYDNSTDGEP | 356 | Q7LFX5 | |
| YNENVTFWHSGEPNN | 161 | Q8WTT0 | |
| FQRYWNSGEPNNSGN | 351 | Q9H2X3 | |
| NYNVESPGQRGFWFD | 251 | Q96PU4 | |
| PGGTDQEGWQYASDF | 881 | Q7Z6L1 | |
| ENEFVYRGNNWPGES | 906 | Q86WI1 | |
| GQGYEDEQDGWNSSS | 186 | Q8NAM6 | |
| STNNWNYSGPGDKFQ | 231 | Q9H2Y7 |